Sechenov School
Home › Pharmacology › Sodium Nitroprusside

Sodium Nitroprusside

*Natrii nitroprussidum*

For medical students2 min readUpdated 2026-10-10

Sodium nitroprusside is a potent vasodilator belonging to the nitric oxide donor drug class. It rapidly decreases blood pressure by simultaneously relaxing arteries and veins, making it an essential medication in emergency cardiology and surgical practice.

DurationExtremely short — effects last only 1–2 minutes
TargetResistance (arteries) and capacitance (veins) blood vessels
EliminationEliminated from the body primarily by the kidneys
AdministrationAdministered exclusively via continuous intravenous infusion

Molecular Mechanism of Action

The pharmacological effect of the drug is mediated by its ability to act as a nitric oxide (NO) donor. Its molecular mechanism is very similar to that of nitroglycerin. The relaxation of the vascular wall occurs in several sequential steps:

  1. Active nitric oxide is released from the administered drug molecule.
  2. The generated NO freely penetrates into the smooth muscle cells forming the walls of blood vessels.
  3. Inside the cell, nitric oxide stimulates the enzyme cytosolic guanylyl cyclase.
  4. Activation of this enzyme leads to a sharp increase in the intracellular level of cyclic guanosine monophosphate (cGMP).
  5. The accumulation of cGMP triggers a cascade of reactions culminating in a drop in cytosolic calcium ion concentration.

This marked deficit in intracellular calcium forces the smooth muscle to relax, leading to vasodilation and a drop in vascular tone.

Hemodynamic Effects

A key feature of sodium nitroprusside, distinguishing it from drugs such as minoxidil or diazoxide, is its non-selective action on the vascular bed. It dilates both resistance vessels (arteries) and capacitance vessels (veins) with equal efficacy.

Its effect on the arterial system leads to a pronounced decrease in total peripheral resistance (TPR) and, consequently, a rapid drop in blood pressure. Its impact on the venous bed triggers the following hemodynamic cascade:

Thus, the drug provides comprehensive unloading of the heart muscle, simultaneously reducing both preload (via veins) and afterload (via arteries).

Pharmacokinetics

The drug possesses unique pharmacokinetic parameters that dictate strict rules for its clinical use. Its therapeutic duration is extremely short, lasting only 1–2 minutes.

Due to this brief period of activity, the only acceptable route of administration is continuous intravenous infusion. This method allows the physician to maintain constant and precise control over the hypotensive effect, instantly adjusting the infusion rate as needed. After administration, drug metabolites are eliminated by the kidneys.

Indications and Side Effects

Owing to its potent and easily manageable hemodynamic profile, the drug is widely used in situations requiring immediate medical intervention:

Despite high clinical efficacy, therapy may be accompanied by several adverse reactions. Major side effects include reflex tachycardia (as a compensatory response to a sharp drop in blood pressure), severe headache (a direct consequence of cerebral vasodilation), and muscle twitching.

Mnemonic

To remember the action profile, use the "Two Fronts" rule: nitroprusside dilates both Arteries (reducing afterload) and Veins (reducing preload).

Frequently asked questions

What side effects does sodium nitroprusside cause?

Common side effects of sodium nitroprusside include:

  • reflex tachycardia;
  • headache;
  • muscle twitching;
  • arterial hypotension;
  • isocyanate toxic effects;
  • risk of cyanide poisoning.

Continuous administration of nitric oxide donors can lead to tolerance.

What toxic metabolites are formed during the biotransformation of sodium nitroprusside in the body?

Toxic effects of isocyanate and the risk of cyanide poisoning are associated with the use of sodium nitroprusside, though specific metabolic pathways generate thiocyanate and cyanide.

What are the contraindications for sodium nitroprusside?

Sodium nitroprusside should be avoided during pregnancy due to the high risk of cyanide poisoning to the fetus. During breastfeeding, risks from cyanide metabolites cannot be excluded. In patients with severe left ventricular hypertrophy and significant aortic stenosis, peripheral vasodilators are generally contraindicated or must be used with extreme caution.

What is the main difference between sodium nitroprusside and minoxidil or diazoxide?

Unlike those drugs, sodium nitroprusside dilates both resistance (arteries) and capacitance (veins) vessels, providing a comprehensive reduction in blood pressure.

Why is the drug administered exclusively via continuous IV infusion?

Its duration of action is only 1–2 minutes. Infusion is necessary to maintain a constant effect and allow instant control over blood pressure levels.

Which enzyme is activated by the drug?

Nitric oxide released from the drug molecule enters the cell and activates cytosolic guanylyl cyclase, leading to an increase in cGMP levels.

How does the drug help in acute heart failure?

It does not directly stimulate the heart, but by dilating veins and arteries, it reduces venous return (preload) and vascular resistance (afterload), thereby effectively "unloading" the myocardium.

Go deeper

More topics in Pharmacology

Cycloferon: Mechanism of Action, Pharmacology, and IndicationsNon-Benzodiazepine AnxiolyticsCycloserineRole of P-glycoproteinPharmacology of Beta-BlockersDirect Thrombin InhibitorsEchinacea PreparationsGonadotropins and GnRH AnalogsDirect Oral Anticoagulants (DOACs)ClomipheneSedative DrugsSympatholyticsPharmacology →